Brightsurf Science News & Current Events

April 17, 2005
Study reveals candidate targets for anti-retroviral therapeutics
The increased frequency of drug resistance in isolates of the AIDS virus, HIV, makes identification of new antiviral targets an urgent necessity.

Measuring enzymes at end of cancer pathway predicts outcome of Tarceva, Taxol
Researchers at The University of Texas M. D. Anderson Cancer Center have developed a way to test whether the new targeted therapy Tarceva and the widely used chemotherapy drug Taxol are effectively killing tumor cells.

Signs of aging: Scientists evaluate genes associated with longevity
Scientists at the BC Cancer Agency's Genome Sciences Centre in Vancouver, British Columbia, Canada, and at the University of Missouri-Columbia have collaborated on a detailed study to elucidate gene-expression patterns implicated in the aging process.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.